Literature DB >> 17417881

Functional characterization of the heterooligomeric EbrAB multidrug efflux transporter of Bacillus subtilis.

Zhongge Zhang1, Che Ma, Owen Pornillos, Xia Xiu, Geoffrey Chang, Milton H Saier.   

Abstract

The Bacillus subtilis genome contains two tandem genes, ebrA and ebrB, which encode two homologues of the SMR family of multidrug efflux transporters. The sequences of EbrA and EbrB are highly similar to each other and to that of EmrE, the prototypical SMR transporter of Escherichia coli. Drug resistance profiling and drug binding experiments showed that the presence of both EbrA and EbrB is required for proper transport function. EbrA and EbrB directly interact and combine to form a functional transporter. They likely form a heterodimer in analogy to the EmrE homodimer. Mutagenesis experiments indicate that the conserved membrane-embedded glutamates in the first transmembrane helices of both EbrA and EbrB are required for multidrug efflux activity. However, the two glutamates are nonequivalent since EbrA E15 is required for substrate binding while EbrB E14 is not. Our studies support a model in which functional residues in EbrAB are relegated to at least two sets that participate in distinct steps of the active drug transport process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417881     DOI: 10.1021/bi7001604

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Topologically random insertion of EmrE supports a pathway for evolution of inverted repeats in ion-coupled transporters.

Authors:  Iris Nasie; Sonia Steiner-Mordoch; Ayala Gold; Shimon Schuldiner
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

2.  X-ray structure of EmrE supports dual topology model.

Authors:  Yen-Ju Chen; Owen Pornillos; Samantha Lieu; Che Ma; Andy P Chen; Geoffrey Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

3.  New substrates on the block: clinically relevant resistances for EmrE and homologues.

Authors:  Iris Nasie; Sonia Steiner-Mordoch; Shimon Schuldiner
Journal:  J Bacteriol       Date:  2012-10-05       Impact factor: 3.490

4.  Global landscape of cell envelope protein complexes in Escherichia coli.

Authors:  Mohan Babu; Cedoljub Bundalovic-Torma; Charles Calmettes; Sadhna Phanse; Qingzhou Zhang; Yue Jiang; Zoran Minic; Sunyoung Kim; Jitender Mehla; Alla Gagarinova; Irina Rodionova; Ashwani Kumar; Hongbo Guo; Olga Kagan; Oxana Pogoutse; Hiroyuki Aoki; Viktor Deineko; J Harry Caufield; Erik Holtzapple; Zhongge Zhang; Ake Vastermark; Yogee Pandya; Christine Chieh-Lin Lai; Majida El Bakkouri; Yogesh Hooda; Megha Shah; Dan Burnside; Mohsen Hooshyar; James Vlasblom; Sessandra V Rajagopala; Ashkan Golshani; Stefan Wuchty; Jack F Greenblatt; Milton Saier; Peter Uetz; Trevor F Moraes; John Parkinson; Andrew Emili
Journal:  Nat Biotechnol       Date:  2017-11-27       Impact factor: 54.908

5.  Comparative analysis of plasmids in the genus Listeria.

Authors:  Carsten Kuenne; Sonja Voget; Jordan Pischimarov; Sebastian Oehm; Alexander Goesmann; Rolf Daniel; Torsten Hain; Trinad Chakraborty
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

6.  An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli.

Authors:  Aixin Yan; Ziqiang Guan; Christian R H Raetz
Journal:  J Biol Chem       Date:  2007-10-10       Impact factor: 5.157

7.  Diversity and evolution of the small multidrug resistance protein family.

Authors:  Denice C Bay; Raymond J Turner
Journal:  BMC Evol Biol       Date:  2009-06-23       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.